CME Group (CME)
(Delayed Data from NSDQ)
$210.94 USD
-1.60 (-0.75%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $210.92 -0.02 (-0.01%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Price, Consensus and EPS Surprise
CME 210.94 -1.60(-0.75%)
Will CME be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CME based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CME
Nasdaq's (NDAQ) Q1 Earnings Miss, Revenues Top, Dividend Raised
CME Group (CME) Q1 Earnings Top Estimates, Revenues Rise Y/Y
CME: What are Zacks experts saying now?
Zacks Private Portfolio Services
CME (CME) Reports Q1 Earnings: What Key Metrics Have to Say
Cracking the Code: 5 Reasons a Choppy Market Looms
Here's What to Expect From CME Group (CME) in Q1 Earnings
Other News for CME
Nasdaq: Operating Leverage Embedded Given Revenue Mix; Multiple Expansion Is Warranted
KBW Reaffirms Their Hold Rating on CME Group (CME)
Analysts Offer Insights on Financial Companies: CME Group (CME) and Synchrony Financial (SYF)
Deep Dive Into CME Gr Stock: Analyst Perspectives (7 Ratings)
CME Group price target raised by $7 at BofA, here's why